H.M. Chan & Co advises key shareholder of Alibaba Health Information Technology in SFC Panel Hearing

H.M. Chan & Co has advised an executive director and substantial shareholder of Alibaba Health Information Technology Limited on the Securities and Futures Commission (SFC) Panel Hearing relating to the HK$1.3 billion takeover of CITIC 21CN Co., Ltd. by Alibaba Group and Yunfeng Capital.

Working closely with Daniel Fung S.C. of Des Voeux Chambers, the H.M. Chan & Co team comprised managing partner Mark Chan, counsel Jennifer Ng and associate Avis Lau.